Identification and Evaluation of Novel Acetolactate Synthase Inhibitors as Antifungal Agents
Authors:
Open Access
- 1 May 2013
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 57 (5) , 2272-2280
Abstract
High-throughput phenotypic screening against the yeast Saccharomyces cerevisiae revealed a series of triazolopyrimidine-sulfonamide compounds with broad-spectrum antifungal activity, no significant cytotoxicity, and low protein binding. To elucidate the target of this series, we have applied a chemogenomic profiling approach using the S. cerevisiae deletion collection. All compounds of the series yielded highly similar profiles that suggested acetolactate synthase (Ilv2p, which catalyzes the first common step in branched-chain amino acid biosynthesis) as a possible target. The high correlation with profiles of known Ilv2p inhibitors like chlorimuron-ethyl provided further evidence for a similar mechanism of action. Genome-wide mutagenesis in S. cerevisiae identified 13 resistant clones with 3 different mutations in the catalytic subunit of acetolactate synthase that also conferred cross-resistance to established Ilv2p inhibitors. Mapping of the mutations into the published Ilv2p crystal structure outlined the chlorimuron-ethyl binding cavity, and it was possible to dock the triazolopyrimidine-sulfonamide compound into this pocket in silico . However, fungal growth inhibition could be bypassed through supplementation with exogenous branched-chain amino acids or by the addition of serum to the medium in all of the fungal organisms tested except for Aspergillus fumigatus . Thus, these data support the identification of the triazolopyrimidine-sulfonamide compounds as inhibitors of acetolactate synthase but suggest that targeting may be compromised due to the possibility of nutrient bypass in vivo .Keywords
This publication has 21 references indexed in Scilit:
- An Integrated Approach for Identification and Target Validation of Antifungal Compounds Active against Erg11pAntimicrobial Agents and Chemotherapy, 2012
- Pathway analysis of Candida albicans survival and virulence determinants in a murine infection modelProceedings of the National Academy of Sciences, 2010
- Evaluation of Lysine Biosynthesis as an Antifungal Drug Target: Biochemical Characterization of Aspergillus fumigatus Homocitrate Synthase and Virulence StudiesEukaryotic Cell, 2010
- Cytocidal amino acid starvation of Saccharomyces cerevisiae and Candida albicans acetolactate synthase (ilv2Δ) mutants is influenced by the carbon source and rapamycinMicrobiology, 2010
- Yeast chemical genomics and drug discovery: an updateTrends in Pharmacological Sciences, 2008
- Acetohydroxyacid synthase and its role in the biosynthetic pathway for branched-chain amino acidsAmino Acids, 2006
- Cryptococcus neoformans Ilv2p confers resistance to sulfometuron methyl and is required for survival at 37 °C and in vivoMicrobiology, 2004
- Biosynthesis of Branched Chain Amino Acids: From Test Tube to FieldThe Plant Cell, 1995
- Mode of action of herbicidal ALS-inhibitors on acetolactate synthase from green plant cell cultures, yeast, andEscherichia coliPesticide Science, 1991
- Mechanism of action of the 1,2,4‐triazolo[1,5‐a] pyrimidinesPesticide Science, 1990